tiprankstipranks
J&J to begin roadshow to pitch shares of consumer-healthcare business, WSJ says
The Fly

J&J to begin roadshow to pitch shares of consumer-healthcare business, WSJ says

Johnson & Johnson is poised to begin a roadshow to pitch shares of its consumer-healthcare business, the producer of household names such as Tylenol, in a test for an IPO market that has been in the doldrums for the past year, The Wall Street Journal’s Corrie Driebusch and Peter Loftus report. Kenvue plans to start meeting with prospective investors as early as Monday, people familiar with the matter said. The goal is to raise $3.5B or more in the offering at a valuation close to $40B, the people said. IPO roadshows typically last anywhere from a few days to a week ahead of the stock’s trading debut, the authors note. Reference Link

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on JNJ:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles